56 related articles for article (PubMed ID: 21472357)
1. Expression of taxol resistance gene 1 correlates with gastric cancer patient clinical outcome and induces taxol resistance.
Bai ZG; Qu X; Han W; Ma XM; Zhao XM; Zhang ZT
Mol Med Rep; 2010; 3(6):1071-8. PubMed ID: 21472357
[TBL] [Abstract][Full Text] [Related]
2. Effects of taxol resistance gene 1 expression on the chemosensitivity of SGC-7901 cells to oxaliplatin.
Liu L; Bai Z; Ma X; Wang T; Yang Y; Zhang Z
Exp Ther Med; 2016 Mar; 11(3):846-852. PubMed ID: 26998002
[TBL] [Abstract][Full Text] [Related]
3. Txr1: an important factor in oxaliplatin resistance in gastric cancer.
Bi J; Bai Z; Ma X; Song J; Guo Y; Zhao J; Yi X; Han S; Zhang Z
Med Oncol; 2014 Feb; 31(2):807. PubMed ID: 24362794
[TBL] [Abstract][Full Text] [Related]
4. Reversal of taxol resistance by cisplatin in nasopharyngeal carcinoma by upregulating thromspondin-1 expression.
Peng X; Li W; Tan G
Anticancer Drugs; 2010 Apr; 21(4):381-8. PubMed ID: 20051827
[TBL] [Abstract][Full Text] [Related]
5. Sensitization of breast cancer cells to taxol by inhibition of taxol resistance gene 1.
Bai Z; Zhang Z; Qu X; Han W; Ma X
Oncol Lett; 2012 Jan; 3(1):135-140. PubMed ID: 22740869
[TBL] [Abstract][Full Text] [Related]
6. Effects of taxol resistance gene 1 on the cisplatin response in gastric cancer.
Duan S; Yin J; Bai Z; Zhang Z
Oncol Lett; 2018 Jun; 15(6):8287-8294. PubMed ID: 29805561
[TBL] [Abstract][Full Text] [Related]
7. TXR1 and TSP1 expression varies by the molecular subtypes of breast cancer patients who received previous docetaxel-based first-line chemotherapy.
Zhang H; Qu X; Ma X; Wang T; Yang Y; Ge Z; Zhang Z; Bai Z; Gao Y; Yuan Z; Wang Z
Exp Biol Med (Maywood); 2016 Nov; 241(17):1919-1923. PubMed ID: 27407097
[TBL] [Abstract][Full Text] [Related]
8. Txr1: a transcriptional regulator of thrombospondin-1 that modulates cellular sensitivity to taxanes.
Lih CJ; Wei W; Cohen SN
Genes Dev; 2006 Aug; 20(15):2082-95. PubMed ID: 16847352
[TBL] [Abstract][Full Text] [Related]
9. [Relations of transforming growth factor-beta1 expression to differentiation and prognosis of advanced gastric cancer].
Guo RF; Zang SZ; Zhang L; Li WM; Hu FL; Lü YY
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3249-54. PubMed ID: 17313802
[TBL] [Abstract][Full Text] [Related]
10. A BTB/POZ gene, NAC-1, a tumor recurrence-associated gene, as a potential target for Taxol resistance in ovarian cancer.
Ishibashi M; Nakayama K; Yeasmin S; Katagiri A; Iida K; Nakayama N; Fukumoto M; Miyazaki K
Clin Cancer Res; 2008 May; 14(10):3149-55. PubMed ID: 18483383
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG
J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223
[TBL] [Abstract][Full Text] [Related]
12. Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin.
Mechetner E; Kyshtoobayeva A; Zonis S; Kim H; Stroup R; Garcia R; Parker RJ; Fruehauf JP
Clin Cancer Res; 1998 Feb; 4(2):389-98. PubMed ID: 9516927
[TBL] [Abstract][Full Text] [Related]
13. Function of Aurora kinase A in Taxol-resistant breast cancer and its correlation with P-gp.
Li Y; Tang K; Zhang H; Zhang Y; Zhou W; Chen X
Mol Med Rep; 2011; 4(4):739-46. PubMed ID: 21584498
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics of taxol in human head and neck tumors.
Gan Y; Wientjes MG; Schuller DE; Au JL
Cancer Res; 1996 May; 56(9):2086-93. PubMed ID: 8616855
[TBL] [Abstract][Full Text] [Related]
15. [Effect of combination of taxol and celecoxib on reversing multidrug resistance human breast cancer cells (MCF-7/ Taxol) and explore its underlying mechanism].
Liu Q; Liu XJ; Chen YJ; Wang J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 May; 42(3):326-30, 357. PubMed ID: 21826992
[TBL] [Abstract][Full Text] [Related]
16. Systematic search for gastric cancer-specific genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer.
Aung PP; Oue N; Mitani Y; Nakayama H; Yoshida K; Noguchi T; Bosserhoff AK; Yasui W
Oncogene; 2006 Apr; 25(17):2546-57. PubMed ID: 16331256
[TBL] [Abstract][Full Text] [Related]
17. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
18. The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer.
Al Sarakbi W; Mokbel R; Salhab M; Jiang WG; Reed MJ; Mokbel K
Anticancer Res; 2006; 26(6C):4985-90. PubMed ID: 17214375
[TBL] [Abstract][Full Text] [Related]
19. MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells.
Li Z; Hu S; Wang J; Cai J; Xiao L; Yu L; Wang Z
Gynecol Oncol; 2010 Oct; 119(1):125-30. PubMed ID: 20624637
[TBL] [Abstract][Full Text] [Related]
20. Effects of protein kinase Cdelta and phospholipase C-gamma1 on monocyte chemoattractant protein-1 expression in taxol-induced breast cancer cell death.
Kim YS; An HT; Kim J; Ko J
Int J Mol Med; 2009 Dec; 24(6):853-8. PubMed ID: 19885629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
